The Riverside Company Acquires Controlling Stake in BioDue S.p.A

Riverside-backed BioDue Acquires Biokosmes and Rolf Kullgren from Venture Life

May 12, 2025

Medical Devices

BioDue S.p.A., a Riverside-backed Italian CDMO, has signed a definitive agreement to acquire Biokosmes S.r.l. and the Rolf Kullgren manufacturing operations (Venture Life Manufacturing AB) from Venture Life Group plc. The add-on expands BioDue’s CDMO footprint—adding manufacturing sites in Northern Italy and Sweden (bringing BioDue to seven plants), broadening its medical device, cosmetics and supplements capabilities, and includes a long-term manufacturing agreement under which Venture Life will remain a customer.

The Riverside Company Acquires Controlling Stake in Essential Compositions

December 19, 2024

Manufacturing

The Riverside Company, via an affiliated European fund, has acquired a controlling stake in Essential Compositions, a Gandía, Spain-based developer and manufacturer of fragrances. Riverside will support the company's commercial and R&D expansion, pursue a buy-and-build strategy in the specialty ingredients/fragrance space, and the Catalá family will reinvest alongside Riverside.

The Riverside Company Invests in Western Botanicals

February 12, 2026

Food & Beverage

The Riverside Company has made a growth investment in Western Botanicals, a Spanish Fork, Utah-based contract development and manufacturing organization (CDMO) of vitamins, minerals and supplements. Riverside will partner with management — which retains a meaningful ownership stake — to support organic growth, expand product and format capabilities, and pursue an M&A strategy to broaden Western Botanicals' capabilities.

The Riverside Company Acquires HealthTech BioActives (HTBA) from Ferrer

December 13, 2019

Pharmaceuticals

The Riverside Company has acquired HealthTech BioActives S.L. (HTBA), a Spanish manufacturer of APIs, excipients, natural flavors and vitamin B12 derivatives, in a carve-out from Ferrer. Riverside will work with HTBA’s ~140 employees and its manufacturing sites in Beniel (Murcia) and Barcelona to strengthen commercial capabilities, accelerate new product development and expand global sales.

The Riverside Company Invests in CRIO, Inc.

May 21, 2024

Cloud & SaaS

The Riverside Company, via its Riverside Micro-Cap Fund, has made a growth investment in CRIO, Inc., a Boston-based provider of cloud-based eSource, CTMS and regulatory-compliance software for clinical trial sites, CROs and pharmaceutical/biotech sponsors. Riverside’s capital will support accelerated product development, broader product offerings and potential strategic acquisitions as CRIO scales.

The Riverside Company Acquires Majority Stake in Montel AS

June 14, 2022

Data & Analytics

The Riverside Company has signed a definitive agreement to acquire a majority stake in Montel AS, a founder- and manager-owned Norwegian provider of energy and electricity market information. Riverside will support Montel's growth by scaling the organization, developing new products, driving geographic expansion and pursuing selective add-on acquisitions while the founder and management team remain with the business.